Form 4: Macrogenics Director Scott Koenig's RSU Vesting
Insider Transaction Report
Macrogenics Director Scott Koenig's restricted stock units vested following a separation and consulting agreement, resulting in the acquisition of 52,829 common shares.
Summary
- Director Scott Koenig acquired a total of 52,829 shares of Macrogenics Inc. common stock on August 13, 2025.
- The acquisition was due to the vesting of restricted stock units (RSUs) pursuant to a Separation and Consulting Agreement between the company and Mr. Koenig.
- Specifically, 50% of outstanding and unvested RSUs immediately vested.
- The vested shares will be delivered to Mr. Koenig as soon as practicable after the vesting date.
- Following these transactions, Mr. Koenig beneficially owns 798,580 shares and 830,244 shares of common stock in two separate reported lines, totaling 1,628,824 shares.
- Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Sentiment
Score: 5
Explanation: The filing reports a routine vesting of restricted stock units for a director following a separation agreement, which is a standard compensation event and does not indicate significant positive or negative operational or financial news for the company.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or operations.
Industry Context
This filing is a routine disclosure of an insider transaction, specifically the vesting of equity awards for a director. It does not provide information related to broader industry trends or competitive landscape, but rather details a specific compensation event for an individual within the company.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | N/A | N/A | 08/13/2025 | The filing indicates a change in the relationship with Director Scott Koenig due to a Separation and Consulting Agreement, which triggered the vesting of restricted stock units. |
Related Party Transactions
- The vesting of restricted stock units for Director Scott Koenig pursuant to a Separation and Consulting Agreement can be considered a related party transaction.
Stakeholder Impact
- Shareholders will note the change in beneficial ownership for Director Scott Koenig, reflecting a pre-arranged compensation event tied to a separation agreement.
Next Steps
- Vested shares will be delivered to the Reporting Person as soon as practicable after the date of vesting.
Key Dates
| Date | Description |
|---|---|
| 08/13/2025 | Date of earliest transaction, when restricted stock units vested and common stock was acquired. |
| 08/15/2025 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
Keywords
Macrogenics, MGNX, Scott Koenig, Restricted Stock Units, RSU, Insider Transaction, SEC Form 4, Beneficial Ownership, Director Compensation, Separation Agreement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.